The Journal of Organic Chemistry
Article
150.4, 127.8, 92.9, 66.2, 62.4, 61.8, 56.6, 20.8, 20.5; HRMS calcd for
C11H16NO8 [M + H]+ 290.0876, found 290.0878.
(4′-Methoxyphenyl)methyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-
α-D-erythro-hex-2-enopyranoside (7c). Using general procedure B,
compound 7c was isolated as a colorless oil: yield 74%; Rf 0.30
(hexane/ethyl acetate, 4:1); [α]2D8 = +165.0 (c 0.80, CH2Cl2); IR
(neat) νmax 2939, 2838, 1746, 1536, 1371, 1354, 1227, 1113, 1070
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.28−7.25 (m, 2H), 7.17 (d, J =
2.0 Hz, 1H), 6.89−6.87 (m, 2H), 5.66 (s, 1H), 5.57 (d, J = 10.6 Hz,
1H), 4.76 (d, J = 10.9 Hz, 1H), 4.66 (d, J = 10.9 Hz, 1H), 4.29−4.18
(m, 3H), 3.79 (s, 3H), 2.11 (s, 6H); 13C NMR (125 MHz, CDCl3) δ
170.6, 169.8, 159.7, 148.2, 132.8, 130.1, 128.4, 114.0, 91.6, 71.5, 66.5,
64.5, 62.0, 55.3, 20.8, 20.7. HRMS calcd for C18H21NNaO9 [M + Na]+
418.1114, found 418.1110.
Cyclohexyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-erythro-hex-
2-enopyranoside (7d). Using general procedure B, compound 7d
was isolated as a colorless oil: yield 62%; Rf 0.50 (hexane/ethyl acetate,
4:1); [α]2D8 = −62.5 (c 0.25, CH2Cl2); IR (neat) νmax 2936, 2859, 1747,
1682, 1536, 1369, 1350, 1222, 1109, 1059 cm−1; 1H NMR (400 MHz,
CDCl3) δ 7.14 (d, J = 2.3 Hz, 1H, H-3), 5.69 (s, 1H, H-1), 5.53 (dd, J
= 2.3, 9.6 Hz, 1H, H-4), 4.30−4.27 (m, 2H, H-6, H-6′), 4.23−4.22 (m,
1H, H-5), 3.76−3.74 (m, 1H, cyclohex-H), 2.13 (s, 3H, COCH3), 2.08
(s, 3H, COCH3), 1.93−1.87 (m, 2H, cyclohex-H), 1.73−1.70 (m, 2H,
cyclohex-H), 1.52−1.26 (m, 6H, cyclohex-H); 13C NMR (125 MHz,
CDCl3) δ 170.6, 169.9, 148.7, 132.2, 91.1, 78.6, 66.3, 64.6, 62.2, 33.4,
31.6, 25.5, 24.0 23.7, 20.8, 20.7; HRMS calcd for C16H23NNaO8 [M +
Na]+ 380.1321, found 380.1324.
Allyl 4,6-Di-O-acetyl-2,3-dideoxy2-nitro-α-D-erythro-hex-2-eno-
pyranoside (7e). Using general procedure B, compound 7e was
isolated as a colorless oil: yield 63%; Rf 0.50 (hexane/ethyl acetate,
4:1); [α]2D8 = +210.0 (c 0.50, CH2Cl2); IR (neat) νmax 2936, 2874,
1746, 1649, 1537, 1428, 1371, 1352, 1109, 1058 cm−1; 1H NMR (500
MHz, CDCl3) δ 7.18 (d, J = 2.1 Hz, 1H), 5.97−5.91 (m, 1H), 5.62 (s,
1H), 5.56 (dd, J = 2.1, 6.7 Hz, 1H), 5.33 (dd, J = 0.9, 17.4 Hz, 1H),
5.25 (dd, J = 0.9, 10.3 Hz, 1H), 4.32−4.20 (m, 5H), 2.13 (s, 3H), 2.10
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.6, 169.8, 148.2, 133.1,
132.8, 118.7, 91.4, 70.6, 66.4, 64.4, 62.0, 20.7; HRMS calcd for
C13H17NaNO8 [M + Na]+ 338.0852, found 338.0855.
General Procedure (C) for the Synthesis of 9a, 9b, and 9c.
To a stirred solution of an acetylated 2-nitroglycal (0.630 mmol) and
TMSN3 (0.694 mmol) or PhSH (0.694 mmol) in dry CH2Cl2 (2 mL)
was added DMAP (3.8 mg, 0.063 mmol) under N2 atmosphere at
room temperature, and the reaction mixture was stirred for 10−15
min. After the consumption of starting material (TLC monitoring),
concentration in vacuo gave a crude residue which was purified by
short column chromatography to obtain pure product (compounds
were not very stable in column).
Benzyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-threo-hex-2-eno-
pyranoside (6b). Using general procedure B, compound 6b was
isolated as a colorless oil: yield: 68%; Rf 0.40 (hexane/ethyl acetate,
4:1); [α]2D8 = −90.0 (c 0.40, CH2Cl2); IR (neat) νmax 2927, 1748, 1537,
1
1371, 1353, 1222, 1061, 1026 cm−1; H NMR (500 MHz, CDCl3) δ
7.38−7.31(m, 5H, Ar−H), 7.28 (d, J = 5.7 Hz, 1H, H-3), 5.77 (s, 1H,
H-1), 5.38 (dd, J = 2.8, 5.7 Hz, 1H, H-4), 4.83 (d, J = 11.2 Hz, 1H,
OCHPh), 4.72 (d, J = 11.2 Hz, 1H, OCHPh), 4.48−4.45 (m, 1H, H-
5), 4.29−4.20 (m, 2H, H-6, H-6′), 2.12 (s, 3H, COCH3), 2.09 (s, 3H,
COCH3); 13C NMR (125 MHz, CDCl3) δ 170.4, 169.7, 150.3, 136.1,
128.5−127.9 (Ar-C), 91.2, 71.3, 66.3, 62.4, 61.7, 20.7, 20.5; HRMS
calcd for C17H19NNaO8 [M + Na]+ 388.1008, found 388.1007.
(4′-Methoxyphenyl)methyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-
α-D-threo-hex-2-enopyranoside (6c). Using general procedure B,
compound 6c was isolated as a colorless oil: yield 84%; Rf 0.35
(hexane/ethyl acetate, 4:1); [α]2D8 = −64.0 (c 0.50, CH2Cl2); IR (neat)
νmax 2937, 1748, 1612, 1536, 1515, 1370, 1354, 1248, 1223, 1060,
1029 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.28−7.25 (m, 3H), 6.90−
6.88 (m, 2H), 5.74 (s, 1H), 5.37 (dd, J = 2.7, 5.4 Hz, 1H), 4.76 (d, J =
10.9 Hz, 1H), 4.64 (d, J = 10.9 Hz, 1H), 4.47−4.44 (m, 1H), 4.28−
4.24 (m, 2H), 3.79 (s, 3H), 2.10 (s, 6H); 13C NMR (125 MHz,
CDCl3) δ 170.2, 169.8, 159.8, 150.5, 130.2, 128.2, 127.9, 114.0, 90.9,
71.0, 66.4, 62.5, 61.8, 55.3, 20.8, 20.5; HRMS calcd for C18H21NNaO9
[M + Na]+ 418.1114, found 418.1111.
Cyclohexyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-threo-hex-2-
enopyranoside (6d). Using general procedure B, compound 6d was
isolated as a colorless crystalline solid: mp 101− 104 °C yield 78%; Rf
0.50 (hexane/ethyl acetate, 4:1); [α]2D8 = −49.3 (c 0.75, CH2Cl2); IR
(neat) νmax 2936, 2859, 1747, 1537, 1370, 1224, 1063, 1031 cm−1; 1H
NMR (500 MHz, CDCl3) δ 7.23 (d, J = 5.7 Hz, 1H), 5.77 (s, 1H),
5.38 (dd, J = 2.9, 5.7 Hz, 1H), 4.49−4.46 (m, 1H), 4.28−4.21 (m,
2H), 3.78−3.74 (m, 1H), 2.10 (s, 3H), 2.06 (s, 3H), 1.93−1.91 (m,
2H), 1.73−1.70 (m, 2H), 1.53−1.19 (m, 6H); 13C NMR (125 MHz,
CDCl3) δ 170.5, 169.8, 151.0, 127.4, 90.7, 78.2, 66.2, 62.7, 61.9, 33.4,
31.5, 25.5, 24.0, 23.8, 20.7, 20.6; HRMS calcd for C16H23NNaO8 [M +
Na]+ 380.1321, found 380.1321.
Allyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-threo-hex-2-enopyr-
anoside (6e). Using general procedure B, compound 6e was isolated
as a colorless oil: yield 67%; Rf 0.40 (hexane/ethyl acetate, 4:1); [α]D28
= −54.0 (c 1.00, CH2Cl2); IR (neat) νmax 2937, 1748, 1645, 1537,
1371, 1352, 1221, 1106, 1063, 1028 cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.27 (d, J = 5.5 Hz, 1H), 5.97−5.89 (m, 1H), 5.71 (s, 1H),
5.39 (dd, J = 2.7, 5.5 Hz, 1H), 5.31 (dd, J = 1.2, 17.1 Hz, 1H), 5.25
(dd, J = 1.2, 10.4 Hz, 1H), 4.44−4.41 (m, 1H), 4.30−4.18 (m, 4H),
2.10 (s, 3H), 2.08 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.5,
169.8, 150.4, 133.1, 127.9, 118.8, 90.9, 70.1, 66.3, 62.5, 61.8, 20.8, 20.6;
HRMS calcd for C13H18NO8 [M + H]+ 316.1032, found 316.1030.
Methyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-erythro-hex-2-
enopyranoside (7a). Using general procedure B, compound 7a was
isolated as a colorless oil: yield 69%; Rf 0.50 (hexane/ethyl acetate,
4:1); [α]2D8 = +117.0 (c 0.35, CH2Cl2); IR (neat) νmax 2938, 1745,
1612, 1534, 1370, 1231, 1109, 1029 cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.17 (d, J = 2.1 Hz, 1H), 5.57−5.55 (m, 1H), 5.46 (s, 1H),
4.28−4.18 (m, 3H), 3.54 (s, 3H), 2.13 (s, 3H), 2.09 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 170.6, 169.8, 148.1, 132.7, 128.1, 93.4, 66.3,
64.4, 62.03, 57.08, 20.79; HRMS calcd for C11H16NO8 [M + H]+
290.0876, found 290.0876
Benzyl 4,6-Di-O-acetyl-2,3-dideoxy-2-nitro-α-D-erythro-hex-2-
enopyranoside (7b). Using general procedure B, compound 7b was
isolated as a colorless oil: yield 56%; Rf 0.45 (hexane/ethyl acetate,
4:1); [α]2D8 = +128.0 (c 0.45, CH2Cl2); IR (neat) νmax 2936, 1745,
1535, 1370, 1350, 1221, 1082, 1025 cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.36−7.33 (m, 5H), 7.19 (d, J = 2.1 Hz, 1H), 5.70 (s, 1H),
5.58 (d, J = 9.4 Hz, 1H), 4.83 (d, J = 11.3 Hz, 1H), 4.75 (d, J = 11.3
Hz, 1H), 4.28−4.16 (m, 3H), 2.12 (s, 3H), 2.10 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 170.6, 169.8, 148.1, 136.4, 132.9−128.4 (Ar−C),
91.9, 71.9, 66.5, 64.4, 61.9, 20.8, 20.7; HRMS calcd for C17H19NaNO8
[M + Na]+ 388.1008, found 388.1008.
((2R,3R,4R)-3-Acetoxy-4-azido-5-nitro-3,4-dihydro-2H-pyran-2-
yl)methyl Acetate (9a). Using general procedure C, compound 9a was
isolated as a colorless oil: yield 78%; Rf 0.60 (hexane/ethyl acetate,
4:1); [α]2D8 = +180.0 (c 0.35, CH2Cl2); IR (neat) νmax 2924, 2853,
2112, 1750, 1640, 1508, 1372, 1349, 1212, 1126, 1052 cm−1; 1H NMR
(500 MHz, CDCl3) δ 8.30 (s, 1H), 5.10 (d, J = 1.7 Hz, 1H), 4.78 (d, J
= 2.8 Hz, 1H), 4.34−4.28 (m, 3H), 2.11 (s, 6H) 13C NMR (125 MHz,
CDCl3) δ 170.3, 169.3, 155.5, 129.2, 72.9, 65.2, 61.0, 52.9, 20.7, 20.6.
HRMS calcd for C10H12NaN4O7 [M + Na]+ 323.0604, found
323.0604.
((2R,3S,4R)-3-Acetoxy-4-azido-5-nitro-3,4-dihydro-2H-pyran-2-
yl)methyl Acetate (9b). Using general procedure C, compound 9b
was isolated as a colorless oil: yield 65%; Rf 0.60 (hexane/ethyl acetate,
4:1); [α]2D8 = +215.0 (c 0.40, CH2Cl2); IR (neat) νmax 2923, 2111,
1748, 1641, 1509, 1369, 1349, 1211, 1158, 1050 cm−1; 1H NMR (500
MHz, CDCl3) δ 8.17 (s, 1H), 5.18 (d, J = 4.2 Hz, 1H), 5.10 (dd, J =
4.2, 10.5 Hz, 1H), 4.46−4.4.37 (m, 3H), 2.19 (s, 3H), 2.11 (s, 3H);
13C NMR (125 MHz, CDCl3) δ 170.3, 169.3, 155.5, 129.2, 72.8, 65.3,
60.4, 53.4, 20.6, 20.4. HRMS calcd for C10H16N5O7 [M + NH4]+
318.1050, found 318.1051.
((2R,3S,4R)-3-Acetoxy-5-nitro-4-(phenylthio)-3,4-dihydro-2H-
pyran-2-yl)methyl Acetate (9c). Using general procedure C,
compound 9c was isolated as a colorless oil: yield 86%; Rf 0.55
(hexane/ethyl acetate, 4:1); [α]2D8 = +95.0 (c 0.20, CH2Cl2); IR (neat)
1
νmax 2964, 2850, 1749, 1638, 1508, 1371, 1344, 1211, 1026 cm−1; H
8447
dx.doi.org/10.1021/jo401165y | J. Org. Chem. 2013, 78, 8442−8450